By Ron Elli, Ph.D.|2026-03-27T17:53:56+00:00July 24th, 2023|Categories: News & Trends|Tags: Amgen, big pharma, celebrity weight loss, Chelsea Handler, Compounded Semaglutide, Eli Lilly, Endocrinology, FDA, GIP, GLP-1, glp1, glucagon, Glucagon-like peptide-1, glycemic control, Ileus, medicated weight loss, novo, NovoNordisk, Orforglipron, Ozempic, Ozempic butt, Retatrutide, Rybelsus, Saxenda, Semaglutide, shot, thyroid cancer, Tirzepatide, Trulicity, type 2 diabetes, Victoza, Wegovy, weight loss injection, weight loss injection shots, Zepbound|2 Comments
The Western world's obsession with finding a magic cure for fatness has come down to a diabetic medicine shot called [...]
By MBC Contributor|2026-03-20T15:39:23+00:00March 7th, 2023|Categories: News & Trends|Tags: Amgen, big pharma, celebrity weight loss, Chelsea Handler, Compounded Semaglutide, Eli Lilly, FDA, GIP, GLP-1, glp1, glucagon, glycemic control, medicated weight loss, novo, NovoNordisk, Orforglipron, Ozempic, Retatrutide, Rybelsus, Saxenda, Semaglutide, shot, thyroid cancer, Tirzepatide, Trulicity, type 2 diabetes, Victoza, Wegovy, weight loss injection, weight loss injection shots, Zepbound|12 Comments
Weight loss can be a daunting task, and sometimes we need a little extra help. With over 650 million obese [...]
